Standout Papers

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response... 2006 2026 2012 2019 4.8k
  1. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response (2006)
    Shideng Bao, Qiulian Wu et al. Nature
  2. IDH1andIDH2Mutations in Gliomas (2009)
    Hai Yan, D. Williams Parsons et al. New England Journal of Medicine
  3. Bevacizumab Plus Irinotecan in Recurrent Glioblastoma Multiforme (2007)
    James J. Vredenburgh, Annick Desjardins et al. Journal of Clinical Oncology
  4. Stem Cell–like Glioma Cells Promote Tumor Angiogenesis through Vascular Endothelial Growth Factor (2006)
    Shideng Bao, Qiulian Wu et al. Cancer Research
  5. Phase II Trial of Bevacizumab and Irinotecan in Recurrent Malignant Glioma (2007)
    James J. Vredenburgh, Annick Desjardins et al. Clinical Cancer Research
  6. Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. (1987)
    Albert J. Wong, Sandra H. Bigner et al. Proceedings of the National Academy of Sciences
  7. Protein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy (2012)
    Huilin Shao, Jaehoon Chung et al. Nature Medicine
  8. Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma (2010)
    John H. Sampson, Amy B. Heimberger et al. Journal of Clinical Oncology
  9. Recurrent Glioblastoma Treated with Recombinant Poliovirus (2018)
    Annick Desjardins, Matthias Gromeier et al. New England Journal of Medicine
  10. Phase II Trial of Gefitinib in Recurrent Glioblastoma (2003)
    Jeremy N. Rich, David A. Reardon et al. Journal of Clinical Oncology
  11. Identification of an Amplified, Highly Expressed Gene in a Human Glioma (1987)
    Kenneth W. Kinzler, Sandra H. Bigner et al. Science

Immediate Impact

10 by Nobel laureates 80 from Science/Nature 209 standout
Sub-graph 1 of 17

Citing Papers

Lysine catabolism reprograms tumour immunity through histone crotonylation
2023 StandoutNature
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer
2020 StandoutNature
23 intermediate papers

Works of Darell D. Bigner being referenced

Improved efficacy against malignant brain tumors with EGFRwt/EGFRvIII targeting immunotoxin and checkpoint inhibitor combinations
2019
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
2006 StandoutNature
and 29 more

Author Peers

Author Last Decade Papers Cites
Darell D. Bigner 21817 18253 15412 619 47.4k
Roger E. McLendon 19151 18272 12748 325 41.0k
Webster K. Cavenee 27510 15661 11287 310 49.9k
Andreas von Deimling 22183 30112 8940 645 57.6k
Henry S. Friedman 14778 21140 8859 564 37.6k
Roger Stupp 15389 30511 9311 373 48.5k
David N. Louis 23780 29974 13929 318 62.6k
Patrick Y. Wen 12006 23253 9683 775 41.8k
David A. Reardon 10207 20314 8565 552 33.1k
Jill S. Barnholtz‐Sloan 11383 18897 6891 433 39.7k
Guido Reifenberger 17931 28242 5692 348 46.0k

All Works

Loading papers...

Rankless by CCL
2026